Infineon Technologies has launched MOTIX TLE9189 gate driver IC, specifically designed for safety-critical applications.

Integral disconnect switches are devices used to isolate electrical circuits by interrupting the flow of electricity. These switches are integral to the equipment they serve, meaning they are built ...

Financing remains a critical issue; Acurx seeks non-dilutive funding from government programs like BARDA, Project BioShield, and potential partnerships to support Phase 3 trials. Readers familiar ...

"Instead of looking at AD just through the usual lens of plaques and tangles, we focused on how specific cell types were changed in each phase," study author Dr. Kyle Travaglini, Ph.D., a ...

BioNTech (NASDAQ:BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for their drug candidate BNT316/ONC-392 in the treatment of non-small cell lung cancer ...

It's a good bet your home's electrical system has one or more disconnect switches. Here's what they are, what they do and why you need them.

Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized ...

3. Either set up or brief the governance team to identify risk, ensure data integrity, and foster accountability throughout AI projects. Communication is key in this phase so ensure teams and ...

“Triphallia, a rare congenital anomaly describing the presence of three distinct penile shafts ... In the womb, the early phase of genital development occurs at four to seven weeks gestation.

We're anticipating another year or so of maximum phase before we really enter the ... Related: 'It was 3 hours of magic': Spectacular auroras thrill stargazers (photos) Sunspots serve as launch ...

they aren't larger than what we might expect during the maximum phase of the cycle." The most powerful flare of the solar cycle so far was an X9.0 on Oct. 3 (X-class denotes the most intense ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...